Share-based Compensation (Tables)
|
3 Months Ended |
Jun. 30, 2026 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Summary of share-based compensation expense |
The following table summarizes the share-based compensation expense for grants included in the Consolidated Statements of Operations:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
(In thousands) |
|
2026 |
|
|
2025 |
|
Product development |
|
$ |
3,761 |
|
|
$ |
3,074 |
|
Sales and marketing |
|
|
578 |
|
|
|
498 |
|
General and administrative |
|
|
1,649 |
|
|
|
1,457 |
|
Total share-based compensation expense |
|
$ |
5,988 |
|
|
$ |
5,029 |
|
|
| Activity related SSARs award |
The following table summarizes the activity during the three months ended June 30, 2026 for SSARs awarded under our Equity Incentive Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands, except share and per share data) |
|
Number of
Rights |
|
|
Weighted-Average
Exercise Price |
|
|
Remaining
Contractual
Term |
|
|
Aggregate
Intrinsic
Value |
|
|
|
|
|
|
(per right) |
|
|
(in years) |
|
|
|
|
Outstanding at April 1, 2026 |
|
|
315,983 |
|
|
$ |
20.02 |
|
|
|
|
|
|
|
Granted |
|
|
— |
|
|
|
0.00 |
|
|
|
|
|
|
|
Exercised |
|
|
(24,690 |
) |
|
|
20.02 |
|
|
|
|
|
|
|
Forfeited |
|
|
— |
|
|
|
0.00 |
|
|
|
|
|
|
|
Expired |
|
|
— |
|
|
|
0.00 |
|
|
|
|
|
|
|
Outstanding at June 30, 2026 |
|
|
291,293 |
|
|
$ |
20.02 |
|
|
|
0.9 |
|
|
$ |
24,608 |
|
Exercisable at June 30, 2026 |
|
|
291,293 |
|
|
$ |
20.02 |
|
|
|
0.9 |
|
|
$ |
24,608 |
|
Vested at June 30, 2026 |
|
|
291,293 |
|
|
$ |
20.02 |
|
|
|
0.9 |
|
|
$ |
24,608 |
|
|
| Activity related to restricted shares awarded by the Company |
The following table summarizes the activity during the three months ended June 30, 2026 for restricted shares awarded under our Equity Incentive Plans:
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
|
Weighted-Average Grant-Date Fair Value |
|
|
|
|
|
|
(per share) |
|
Outstanding at April 1, 2026 |
|
|
74,792 |
|
|
$ |
94.58 |
|
Granted |
|
|
7,570 |
|
|
|
79.25 |
|
Vested |
|
|
(11,141 |
) |
|
|
76.92 |
|
Forfeited |
|
|
(375 |
) |
|
|
90.85 |
|
Expected to vest at June 30, 2026 |
|
|
70,846 |
|
|
$ |
95.75 |
|
|
| Employee Stock [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of principal assumptions utilized in valuing service condition SARs |
We used the following inputs including principal assumptions for the following offering period reflected in our consolidated financial statements:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering Period Ended |
|
|
Offering Period Ended |
|
|
Offering Period Ended |
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
|
June 30, 2025 |
|
Grant date fair value |
|
$ |
118.84 |
|
|
$ |
115.19 |
|
|
$ |
131.71 |
|
Risk-free interest rate over contractual term |
|
|
3.62 |
% |
|
|
4.30 |
% |
|
|
4.31 |
% |
Expected term (in years) |
|
|
0.49 |
|
|
|
0.50 |
|
|
|
0.49 |
|
Expected volatility |
|
|
45.17 |
% |
|
|
60.10 |
% |
|
|
42.40 |
% |
|
| Restricted Stock Units (RSUs) [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Activity related to restricted shares awarded by the Company |
The following table summarizes the activity during three months ended June 30, 2026 for restricted stock units awarded under our Equity Incentive Plans:
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
|
Weighted-Average Grant-Date Fair Value |
|
|
|
|
|
|
(per share) |
|
Outstanding at April 1, 2026 |
|
|
290,955 |
|
|
$ |
128.87 |
|
Granted |
|
|
89,298 |
|
|
|
77.51 |
|
Vested |
|
|
(7,091 |
) |
|
|
103.36 |
|
Forfeited |
|
|
(2,074 |
) |
|
|
130.85 |
|
Expected to vest at June 30, 2026 |
|
|
371,088 |
|
|
$ |
116.99 |
|
|
| Summary of Valuation Assumptions and Fair value of Restricted Stock Units |
The following table summarizes the principal valuation assumptions utilized and the resulting fair value of restricted stock units subject to a market condition granted in fiscal 2027:
|
|
|
|
|
|
|
2026 |
|
Risk-free interest rate over contractual term |
|
|
4.2 |
% |
Expected volatility |
|
|
49.0 |
% |
Weighted-average grant date fair value |
|
$60.33 - $73.76 |
|
|